The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women
Abstract
Hormone replacement therapy (HRT) is the most commonly used treatment for managing menopausal symptoms and has been shown to be the most effective intervention in this context. The decision whether to take HRT, the dose of HRTused and the duration of its use should be made on an individualised basis after discussing the benefits and risks with each patient. Arbitrary limits should not be placed on the duration of usage of HRT.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Higher doses of estrogen need higher doses of micronized progesterone (300 mg daily for 12 days per month or 200 mg daily).
“Higher doses of estrogen need higher doses of micronized progesterone (300 mg daily for 12 days per month or 200 mg daily).”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [305]
Endometrial protection is better in those women using a continuous combined regimen.
“In general, endometrial protection is better in those women using a continuous combined regimen.”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [305]
The citation lists haven’t been fetched yet
References 180 · Cited by 192
- Authors
- Hamoda, H., Panay, N., Pedder, H., Arya, R., & Savvas, M.
- Affiliations
- King's College Hospital (GB)
- Queen Charlotte's and Chelsea Hospital (GB)
- University of Bristol (GB)
- Corresponding author
- Hamoda, Haitham
- Venue
- Post Reproductive Health
- Publisher
- Informa UK Limited
- Published
- 2020-10-12
- Volume
- 26
- Issue
- 4
- Pages
- 181-209
- ISSN
- 2053-3370 (ISSN-L)
- 2053-3691
- 2053-3705
- OpenAlex
- W3092559956
- Semantic Scholar
- 42412ac9a2f745a7dbd78d5e573a3bb20ad3141f
- Cited by
- 192
- References
- 180
- Citations by year
- 2026: 24 · 2025: 44 · 2024: 38 · 2023: 28 · 2022: 40 · 2021: 12 · 2020: 3 · 2018: 1 · 2017: 2
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Post Reproductive Health (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- hormone replacement therapy, menopause, postmenopausal women, clinical guidelines
- MeSH terms
- Female, Humans, Menopause, Estrogen Replacement Therapy, Women's Health, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
